Hugel, Inc.

145020 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩231,000.00
-2.12%
Delayed · cached 15 min

Fair value analysis

145020
Hugel, Inc.
PharmaceuticalsPharmaceuticals
₩231,000.00
Close used for this calculation
₩293,445.81Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
71/100
Profitability23/25
Returns10/25
Balance Sheet23/25
Efficiency15/25
Growth17/25
Strong
Quality radar
71Prof.23/25Ret.10/25Eff.15/25B.Sht23/25Growth17/25

Consensus fair value

₩293,445.81
Below FV
▲ +27.0% against the close used
Model range ₩160,659.94 – ₩829,983.01
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩160,659.94Fair value₩293,445.81Bull₩829,983.01
FairClose
52-week traded range
52W low ₩214,000.0052W high ₩326,000.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Hugel, Inc. closed at ₩231,000.00, 21.3% below the consensus fair value of ₩293,445.81 drawn from 9 valuation models.

Financial DNA score 71/100 — Strong. P/E of 17.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩241,061.97
+4.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩160,659.94
-30.5%
√(22.5 × EPS × BVPS)
EPS=13061, BVPS=87832.7 · outside Graham range (P/E 17.7, P/B 2.6) — asset-light, treat as a rough floor
Graham Formula
₩829,983.01
+259.3%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=19.6%, FD=3.3%
P/E Fair Value
₩261,220.00
+13.1%
EPS × 20x (sector P/E)
EPS=13061, Sector P/E=20x
Peter Lynch (PEG)
₩255,734.38
+10.7%
EPS × Growth% (PEG = 1 is fair)
EPS=13061, g=19.6%
EV/EBITDA
₩321,278.95
+39.1%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=200.85B
Book Value (P/B)
₩193,671.10
-16.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=87832.7, ROE=14.8%, g=6%, r=10%
Reverse DCF
₩231,000.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 5.5% | Historical: 19.6%
Margin of Safety
₩279,923.42
+21.2%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=373231.23, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.